SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-065292
Filing Date
2024-05-28
Accepted
2024-05-28 16:36:35
Documents
1
Period of Report
2024-05-23

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3749
  Complete submission text file 0000950170-24-065292.txt   5345
Mailing Address 260 SHERIDAN AVENUE SUITE 400 PALO ALTO CA 94306
Business Address 260 SHERIDAN AVENUE SUITE 400 PALO ALTO CA 94306 650-800-6676
Vincerx Pharma, Inc. (Issuer) CIK: 0001796129 (see all company filings)

IRS No.: 833197402 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 260 SHERIDAN AVENUE, SUITE 400 PALO ALTO CA 94306
Business Address
Stevens Ruth E. (Reporting) CIK: 0001856230 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39244 | Film No.: 24992521